50 Participants Needed

PelvicSense Program for Vulvodynia

CP
Overseen ByCaroline Pukall, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Dr. Caroline Pukall
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study will examine the effectiveness of the PelvicSense 3-month online program on pain and other outcomes in those with provoked vestibulodynia. This study is prospective in nature and will involve several assessment points: baseline, immediately post-treatment (at the end of the 3 month program), and 3-month follow up. All aspects of the study will be conducted remotely (e.g., online, email, video calls), and participants will be at least 18 years of age, fluent in English, and experience pain due to provoked vestibulodynia for at least 3 months with a physician diagnosis. Participants are expected to continue their treatment as usual and this information will be documented throughout the study.

Will I have to stop taking my current medications?

No, you will not have to stop taking your current medications. Participants are expected to continue their treatment as usual during the study.

How is the PelvicSense treatment for vulvodynia different from other treatments?

The PelvicSense treatment is unique because it is an online program specifically designed to address vulvodynia, a condition with no standard treatment, by potentially focusing on pelvic alignment and dynamics, which may influence pelvic pain.12345

Who Is on the Research Team?

CP

Caroline Pukall, PhD

Principal Investigator

Queen's University

Are You a Good Fit for This Trial?

This trial is for adults over 18 who speak English and have been diagnosed with provoked vestibulodynia, a condition causing pain in the vulvar region, for at least three months. Participants will engage in an online program called PelvicSense and must continue their usual treatment during the study.

Inclusion Criteria

Fluent in English
I have been diagnosed with peripheral vascular disease for at least 3 months.

Exclusion Criteria

I am not fluent in English.
Self-identified diagnosis
My peripheral vascular disease has lasted less than 3 months.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in the PelvicSense 3-month online program focusing on physiotherapy techniques

12 weeks
Remote sessions (online, email, video calls)

Follow-up

Participants are monitored for pain and sexual outcomes 3 months after the end of the program

3 months
Remote assessments

What Are the Treatments Tested in This Trial?

Interventions

  • PelvicSense(R)
Trial Overview The effectiveness of PelvicSense, a 3-month online program designed to help manage pain and improve sexual outcomes for those suffering from provoked vestibulodynia, is being tested. The study includes assessments before starting, after completing the program, and three months later.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: 3 month PelvicSense(R) programExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dr. Caroline Pukall

Lead Sponsor

Trials
3
Recruited
130+

Dr. Caroline Pukall

Lead Sponsor

Trials
3
Recruited
130+

Queen's University

Lead Sponsor

Trials
382
Recruited
122,000+

Published Research Related to This Trial

A study using MRI and ultrasound to analyze pelvic landmarks in different seating positions found that internal and external landmark coordinates are generally statistically different, influenced by soft tissue thickness and posture changes.
Despite these differences, the accuracy of estimating pelvic orientation indexes (like tilt and rotation) was not significantly affected, suggesting that linear regressions can be used to correlate internal and external landmark positions.
Differences between pelvic skin and bone landmark identification in different seated positions on spinal-cord injured subjects.Lalonde, NM., Dansereau, J., Aissaoui, R., et al.[2019]
A study involving 102 women found that those with dysmenorrhea (menstrual pain) had a greater pelvic torsion (2.4 degrees) compared to those without dysmenorrhea (1.7 degrees), indicating a potential link between pelvic alignment and menstrual pain.
The research utilized advanced measurement techniques (Formetric 4D) to assess pelvic alignment, suggesting that pelvic torsion may play a role in the experience of dysmenorrhea.
The relationship between pelvic alignment and dysmenorrhea.Kim, MJ., Baek, IH., Goo, BO.[2020]
Patient Assisted Laparoscopy (PAL) significantly reduced the negative laparoscopy rate for patients with pelvic pain to less than 3%, compared to the typical 35% seen with traditional laparoscopic procedures under general anesthesia.
Out of 100 patients assessed, 88 were successfully evaluated, revealing that a majority (61 patients) had endometriosis, highlighting PAL's effectiveness in diagnosing specific causes of chronic pelvic pain.
Effect on negative laparoscopy rate in chronic pelvic pain patients using patient assisted laparoscopy.Demco, LA.[2023]

Citations

Differences between pelvic skin and bone landmark identification in different seated positions on spinal-cord injured subjects. [2019]
The relationship between pelvic alignment and dysmenorrhea. [2020]
Effect on negative laparoscopy rate in chronic pelvic pain patients using patient assisted laparoscopy. [2023]
Simulation of normal pelvic mobilities in building an MRI-validated biomechanical model. [2021]
Characterizing pelvis dynamics in adolescent with idiopathic scoliosis. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security